Breaking News

PPD Expands Early Development Research Capabilities

Adds neuroscience and ethno-bridging expertise, broadening capabilities to provide increased access to patients and special populations at its CRUs

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

PPD, Inc. has expanded its early development research services by adding significant neuroscience and ethno-bridging expertise, broadening its capabilities to provide increased access to patients and special populations at PPD-owned clinical research units (CRUs).   The company has added a 52-bed CRU in Orlando, FL, enhancing its ability to conduct complex, procedurally intensive Phase I and Phase Ib early development clinical research in neurology. The recently acquired unit has a track recor...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters